中国医药
中國醫藥
중국의약
CHINA MEDICINE
2013年
1期
57-59
,共3页
王寿世%宋婷婷%黑飞龙%陆惠元%宁吉顺%曹焕军%兰克涛
王壽世%宋婷婷%黑飛龍%陸惠元%寧吉順%曹煥軍%蘭剋濤
왕수세%송정정%흑비룡%륙혜원%저길순%조환군%란극도
心肌保护%心肌停搏液%离体心脏灌流模型%糖尿病
心肌保護%心肌停搏液%離體心髒灌流模型%糖尿病
심기보호%심기정박액%리체심장관류모형%당뇨병
Myocardial preservation%Cardioplegic solution%Langendorff model%Diabete
目的 探讨离体糖尿病大鼠心肌对缺血再灌注损伤的耐受性.方法 将44只SD大鼠完全随机分为非糖尿病对照组、非糖尿病托马斯停搏液(STH-2)组和糖尿病对照组、糖尿病STH-2组,各11只,糖尿病对照组和糖尿病STH-2组均建立糖尿病大鼠模型.4组大鼠均使用离体心脏灌流装置测定心功能指数及冠状动脉肌钙蛋白漏出含量,并观察心肌组织超微结构改变.结果 非糖尿病STH-2组心脏保存4h后左心室形成压(LVDP)及左心室内压变化最大速率(±dp/dtmax)均明显低于非糖尿病对照组[LVDP:(162 ±41)mm Hg(1 mm Hg =0.133 kPa)比(344±37)mm Hg; dp/dtmax:(4340±156) mm Hg/s比(10 438±252)mm Hg/s;-dp/dtmax:(2440±152) mm Hg/s比(4942±78)mm Hg/s],差异均有统计学意义(均P<0.05);糖尿病STH-2组心脏保存4h后LVDP、±dp/dtmax亦有不同程度的下降[分别为(148±13) mm Hg、(2586±34)mm Hg/s、(2135 ±82)mm Hg/s],但与糖尿病对照组相比差异均无统计学意义(均P>0.05);糖尿病组LVDP、±dp/dtmax均低于对应的非糖尿病组(均P<0.05).非糖尿病STH-2组肌钙蛋白漏出含量明显高于非糖尿病对照组[(0.190 ±0.020) μ g/L比(0.020 ±0.001) μg/L,P<0.05];糖尿病STH-2组肌钙蛋白漏出含量明显高于糖尿病对照组[(0.360±0.050) μ g/L比(0.140±0.030) μg/L,P<0.05];非糖尿病STH-2组肌钙蛋白漏出量低于糖尿病STH-2组,差异有统计学意义(P<0.01).电镜观察显示,非糖尿病对照组心肌结构基本正常,而非糖尿病STH-2组变化明显.糖尿病组较非糖尿病组心肌结构变化明显,心肌纤维化、线粒体增生数量明显增多.结论 糖尿病大鼠心肌对缺血再灌注损伤的耐受性优于非糖尿病大鼠.
目的 探討離體糖尿病大鼠心肌對缺血再灌註損傷的耐受性.方法 將44隻SD大鼠完全隨機分為非糖尿病對照組、非糖尿病託馬斯停搏液(STH-2)組和糖尿病對照組、糖尿病STH-2組,各11隻,糖尿病對照組和糖尿病STH-2組均建立糖尿病大鼠模型.4組大鼠均使用離體心髒灌流裝置測定心功能指數及冠狀動脈肌鈣蛋白漏齣含量,併觀察心肌組織超微結構改變.結果 非糖尿病STH-2組心髒保存4h後左心室形成壓(LVDP)及左心室內壓變化最大速率(±dp/dtmax)均明顯低于非糖尿病對照組[LVDP:(162 ±41)mm Hg(1 mm Hg =0.133 kPa)比(344±37)mm Hg; dp/dtmax:(4340±156) mm Hg/s比(10 438±252)mm Hg/s;-dp/dtmax:(2440±152) mm Hg/s比(4942±78)mm Hg/s],差異均有統計學意義(均P<0.05);糖尿病STH-2組心髒保存4h後LVDP、±dp/dtmax亦有不同程度的下降[分彆為(148±13) mm Hg、(2586±34)mm Hg/s、(2135 ±82)mm Hg/s],但與糖尿病對照組相比差異均無統計學意義(均P>0.05);糖尿病組LVDP、±dp/dtmax均低于對應的非糖尿病組(均P<0.05).非糖尿病STH-2組肌鈣蛋白漏齣含量明顯高于非糖尿病對照組[(0.190 ±0.020) μ g/L比(0.020 ±0.001) μg/L,P<0.05];糖尿病STH-2組肌鈣蛋白漏齣含量明顯高于糖尿病對照組[(0.360±0.050) μ g/L比(0.140±0.030) μg/L,P<0.05];非糖尿病STH-2組肌鈣蛋白漏齣量低于糖尿病STH-2組,差異有統計學意義(P<0.01).電鏡觀察顯示,非糖尿病對照組心肌結構基本正常,而非糖尿病STH-2組變化明顯.糖尿病組較非糖尿病組心肌結構變化明顯,心肌纖維化、線粒體增生數量明顯增多.結論 糖尿病大鼠心肌對缺血再灌註損傷的耐受性優于非糖尿病大鼠.
목적 탐토리체당뇨병대서심기대결혈재관주손상적내수성.방법 장44지SD대서완전수궤분위비당뇨병대조조、비당뇨병탁마사정박액(STH-2)조화당뇨병대조조、당뇨병STH-2조,각11지,당뇨병대조조화당뇨병STH-2조균건립당뇨병대서모형.4조대서균사용리체심장관류장치측정심공능지수급관상동맥기개단백루출함량,병관찰심기조직초미결구개변.결과 비당뇨병STH-2조심장보존4h후좌심실형성압(LVDP)급좌심실내압변화최대속솔(±dp/dtmax)균명현저우비당뇨병대조조[LVDP:(162 ±41)mm Hg(1 mm Hg =0.133 kPa)비(344±37)mm Hg; dp/dtmax:(4340±156) mm Hg/s비(10 438±252)mm Hg/s;-dp/dtmax:(2440±152) mm Hg/s비(4942±78)mm Hg/s],차이균유통계학의의(균P<0.05);당뇨병STH-2조심장보존4h후LVDP、±dp/dtmax역유불동정도적하강[분별위(148±13) mm Hg、(2586±34)mm Hg/s、(2135 ±82)mm Hg/s],단여당뇨병대조조상비차이균무통계학의의(균P>0.05);당뇨병조LVDP、±dp/dtmax균저우대응적비당뇨병조(균P<0.05).비당뇨병STH-2조기개단백루출함량명현고우비당뇨병대조조[(0.190 ±0.020) μ g/L비(0.020 ±0.001) μg/L,P<0.05];당뇨병STH-2조기개단백루출함량명현고우당뇨병대조조[(0.360±0.050) μ g/L비(0.140±0.030) μg/L,P<0.05];비당뇨병STH-2조기개단백루출량저우당뇨병STH-2조,차이유통계학의의(P<0.01).전경관찰현시,비당뇨병대조조심기결구기본정상,이비당뇨병STH-2조변화명현.당뇨병조교비당뇨병조심기결구변화명현,심기섬유화、선립체증생수량명현증다.결론 당뇨병대서심기대결혈재관주손상적내수성우우비당뇨병대서.
Objective To explore the tolerance of diabetic rat's isolated myocardium on ischemiareperfusion injury.Methods All 44 male SD rats were randomly divided into non diabetic control group,nondiabetic STH-2 (St.Thomas Hospital 2) group,diabetic control group and diabetic STH-2 group (with 11 rats in each group).Cardiac function index included left ventricular developed pressure(LVDP) ; ± dp/dtmax was determined by Powerlab physiological functions recorder; troponin was measured and mycardiol ultramicrostructure was observed.Results Between non-diabetic control group and non-diabetic STH-2 group,LVDP and ± dp/dtmax had significant difference after hearts being preserved for 4 hours [LVDP:(162 ± 41)mm Hg(1 mm Hg =0.133 kPa) vs (344 ±37) mm Hg; dp/dtmax:(4340 ± 156) mm Hg/s vs (10 438 ±252) mm Hg/s;-dp/dtmax:(2440 ± 152) mm Hg/s vs (4942 ± 78) mm Hg/s] (all P < 0.05).Compared with diabetic control group,LVDP and ± dp/dtmax also decreased after being preserved for 4 hours in diabetic STH-2 group [(148 ± 13)mm Hg,(2586 ±34) mm Hg/s,(2135 ± 82)mm Hg/s,respectively],but there was no significant difference (all P > 0.05).The diabetic groups had low cardiac function index compared with non-diabetic groups (P <0.05).The troponin in non-diabetic STH-2 group and diabetic STH-2 group was higher than that in non-diabetic control group and diabetic control group [(0.190 ±0.020) μg/L vs (0.020 ±0.001) μg/L,(0.360 ±0.050) μ g/L vs (0.140 ±0.030)μg/L,all P<0.05] ; the troponin in diabetic STH-2 group was higher than that in non-diabetic STH-2 group,and the difference was significant (P < 0.01).In non-diabetic groups,electron microscope result showed that control group had normal ultramicrostructure.Diabetic groups had worse ultramicrostructure compared with non-diabetic groups.Heart muscle fibrosis and mitochondria hyperplasia were the main findings.Conclusions The diabetic rat heart has higher myocardial ischemia-reperfusion injury tolerance than non-diabetic rat heart.